ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: Chapel Hill

G1 Therapeutics developing treatment to protect soldiers, chemo patients from radiation damage

G1 Therapeutics developing treatment to protect soldiers, chemo patients from radiation damage

May 1, 2013 7:51 am by | 0 Comments

After the Boston Marathon bombing, it’s easy to understand why the government is giving G1 Therapeutics millions of dollars to develop a pill that protects against radiation exposure.If the pressure-cooker ... Read more
Heat Biologics gets $5M to usher heat shock protein therapy into phase 2 lung cancer trials

Heat Biologics gets $5M to usher heat shock protein therapy into phase 2 lung cancer trials

April 17, 2013 4:30 pm by | 0 Comments

A company developing an off-the-shelf immunotherapy that it thinks can turn tumors into adjuvant-secreting machines has some fresh capital as it heads into phase 2 clinical trials.Twenty investors have put ... Read more
UNC spinout wants to help health workers wipe out surface contamination by harmful cancer drugs

UNC spinout wants to help health workers wipe out surface contamination by harmful cancer drugs

March 12, 2013 11:02 am by | 0 Comments

Chemotherapy drugs used today are potent and nonselective, meaning they kill both cancerous and non-cancerous cells. That’s why many cancer patients experience so many troublesome side effects. It’s also why ... Read more
Biopharmaceutical startup developing heart failure therapeutic raises more than $28M

Biopharmaceutical startup developing heart failure therapeutic raises more than $28M

November 7, 2012 7:46 pm by | 0 Comments

A drug developer with a treatment for acute decompensated heart failure, one of the leading reasons for hospitalization, has raised more than $28 million. ... Read more
A surprising reason why some newborns test positive for marijuana

A surprising reason why some newborns test positive for marijuana

June 4, 2012 2:48 pm by | 10 Comments

Some newborns are testing positive for marijuana exposure and the reason why could surprise you.Soap and hand wash products, including products commonly used in hospital nurseries, can interfere with urine ... Read more
Hepatitis C, liver cancer research at UNC secures $2.3M federal grant

Hepatitis C, liver cancer research at UNC secures $2.3M federal grant

May 17, 2012 2:35 pm by | 0 Comments

The hepatitis C virus is believed to have links to the growth of liver cancer, but those connections have been hard to study. University of North Carolina at Chapel Hill ... Read more
Unlocking university innovation: UNC’s Rose nurtures new life science startups

Unlocking university innovation: UNC’s Rose nurtures new life science startups

May 9, 2012 4:23 pm by | 0 Comments

Don Rose has a front seat to watch many of the emerging life science companies around North Carolina’s Research Triangle Park.Rose is executive director of Carolina KickStart, a University of ... Read more
Pozen migraine drug licensed to Desitin for commercialization in Europe

Pozen migraine drug licensed to Desitin for commercialization in Europe

May 8, 2012 11:11 am by | 0 Comments

The migraine headache treatment developed by Pozen (NASDAQ:POZN) now has a partner for commercialization in Europe.Pozen licensed the compound MT 400 to German central nervous system therapies company Desitin in ... Read more
How arthritis drug Vimovo could ease Pozen’s PA32540 regulatory pain

How arthritis drug Vimovo could ease Pozen’s PA32540 regulatory pain

May 1, 2012 5:26 pm by | 0 Comments

Osteoarthritis drug Vimovo‘s sales disappointed early and its U.S. prescriptions have declined as of late, but for all of those commercialization pains, the drug has become an unexpected regulatory beacon ... Read more
FDA concerns may limit cardiovascular approval of Pozen’s safer aspirin

FDA concerns may limit cardiovascular approval of Pozen’s safer aspirin

April 30, 2012 2:52 pm by | 0 Comments

Pozen (NASDAQ:POZN), now prepping to file a new drug application for its safer form of aspirin, has run into a slight regulatory headache.The company had looked on track way for ... Read more
UNC’s Emerging Company Showcase highlights new healthcare technologies

UNC’s Emerging Company Showcase highlights new healthcare technologies

April 20, 2012 12:57 pm by | 1 Comments

Innovation is brewing in Chapel Hill, North Carolina.The University of North Carolina at Chapel Hill held its annual Emerging Company Showcase this week, an event that gives companies spun out ... Read more
IMRT beats proton therapy in prostate cancer, UNC comparative study says

IMRT beats proton therapy in prostate cancer, UNC comparative study says

April 17, 2012 3:54 pm by | 0 Comments

In prostate cancer treatment, newer might not necessarily be better.University of North Carolina at Chapel Hill research has found that intensity modulated radiation therapy, or IMRT, is as effective and ... Read more
Antibiotics developer Cempra sees opportunity in prosthetic joint infections

Antibiotics developer Cempra sees opportunity in prosthetic joint infections

March 30, 2012 1:41 pm by | 0 Comments

Cempra (NASDAQ:CEMP) CEO Prabhavathi Fernandes speaks with urgency these days, particularly when discussing the antibiotics compounds her company plans for new drug applications in 2015.The Chapel Hill, North Carolina company ... Read more
Safer aspirin is strong in phase 3; Pozen plans 3Q NDA filing

Safer aspirin is strong in phase 3; Pozen plans 3Q NDA filing

March 22, 2012 11:18 am by | 0 Comments

The delayed-release aspirin compound that Pozen (NASDAQ:POZN) has developed to protect against cardiovascular disease showed in clinical trials that it causes fewer ulcers compared to aspirin alone.With those positive phase ... Read more
UNC kidney cancer research awarded $843K SAIC-Frederick contract

UNC kidney cancer research awarded $843K SAIC-Frederick contract

March 13, 2012 4:32 pm by | 0 Comments

Kidney cancer research at the University of North Carolina at Chapel Hill is getting a funding boost from SAIC-Frederick with the goal of developing new treatments for renal cell carcinoma, ... Read more